HLT, Inc. Gains FDA Approval for Two TAVR Clinical Studies

The studies will assess the performance of its HLT Meridian® TAVR® Valve System to treat aortic stenosis and aortic regurgitation for high-risk patients suffering from aortic disease MAPLE GROVE, Minn., March 24, 2022 -- (Healthcare Sales & Mark... Devices, Interventional, Cardiology, FDA HLT, transcatheter, aortic valve replacement, TAVR, aortic stenosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news